200 related articles for article (PubMed ID: 28398584)
21. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
22. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM
Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000
[TBL] [Abstract][Full Text] [Related]
23. Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.
Appolloni I; Alessandrini F; Ceresa D; Marubbi D; Gambini E; Reverberi D; Loiacono F; Malatesta P
Cancer Lett; 2019 Feb; 442():213-221. PubMed ID: 30312732
[TBL] [Abstract][Full Text] [Related]
24. Brain Tumors of Glial Origin.
Waker CA; Lober RM
Adv Exp Med Biol; 2019; 1190():281-297. PubMed ID: 31760651
[TBL] [Abstract][Full Text] [Related]
25. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.
Agnihotri S; Aldape KD; Zadeh G
Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382
[TBL] [Abstract][Full Text] [Related]
26. Primary and secondary glioblastomas: from concept to clinical diagnosis.
Kleihues P; Ohgaki H
Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
[TBL] [Abstract][Full Text] [Related]
27. Cell Lineage-Based Stratification for Glioblastoma.
Wang Z; Sun D; Chen YJ; Xie X; Shi Y; Tabar V; Brennan CW; Bale TA; Jayewickreme CD; Laks DR; Alcantara Llaguno S; Parada LF
Cancer Cell; 2020 Sep; 38(3):366-379.e8. PubMed ID: 32649888
[TBL] [Abstract][Full Text] [Related]
28. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
[TBL] [Abstract][Full Text] [Related]
29. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
30. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors.
Patel RR; Ramkissoon SH; Ross J; Weintraub L
Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112
[TBL] [Abstract][Full Text] [Related]
31. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
[TBL] [Abstract][Full Text] [Related]
32. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
[TBL] [Abstract][Full Text] [Related]
33. Glioblastoma models driven by different mutations converge to the proneural subtype.
Alessandrini F; Ceresa D; Appolloni I; Pagani F; Poliani PL; Marubbi D; Malatesta P
Cancer Lett; 2020 Jan; 469():447-455. PubMed ID: 31733287
[TBL] [Abstract][Full Text] [Related]
34. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
Rahme GJ; Luikart BW; Cheng C; Israel MA
Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
[TBL] [Abstract][Full Text] [Related]
35. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
36. Genomic profiles of glioma.
Brennan C
Curr Neurol Neurosci Rep; 2011 Jun; 11(3):291-7. PubMed ID: 21465149
[TBL] [Abstract][Full Text] [Related]
37. Immunological classification of gliomas based on immunogenomic profiling.
Feng Q; Li L; Li M; Wang X
J Neuroinflammation; 2020 Nov; 17(1):360. PubMed ID: 33246490
[TBL] [Abstract][Full Text] [Related]
38. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
39. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
Gressot LV; Doucette TA; Yang Y; Fuller GN; Heimberger AB; Bögler O; Rao A; Latha K; Rao G
Int J Cancer; 2015 May; 136(9):2047-54. PubMed ID: 25302990
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells are enriched in the side population cells in a mouse model of glioma.
Harris MA; Yang H; Low BE; Mukherjee J; Guha A; Bronson RT; Shultz LD; Israel MA; Yun K
Cancer Res; 2008 Dec; 68(24):10051-9. PubMed ID: 19074870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
